Biotech Industry Curtails Pharma Crops

After more than a year of intense discussion, the Biotechnology Industry Organization (BIO) has voluntarily decided to stop growing some crops that are bioengineered for pharmaceutical and industrial purposes. The decision's intent is to ease fears of accidental contamination of food or animal feed in Midwestern and Plains states.

Most immediately, it will bar companies from planting certain types of gene-altered corn in the Midwest. Though voluntary, a dozen companies in the U.S. and Canada that are trying to produce pharmaceutical and industrial chemicals in plants have endorsed it.

If you're in the Corn Belt with a test plot today, you will not be there as a BIO member company in 2003, says Michael Phillips, executive director for BIO.

The industry agreed not to plant such crops in Illinois, Indiana, Iowa, most of Missouri and part of Ohio, Minnesota, South Dakota, Nebraska and Kentucky.

Discuss this article 0

Post new comment
Sign In or register to use your Corn and Soybean Digest ID
(optional)

Get the latest insights into the technology and trends shaping the industry

n/a
Continuing Education Courses
This online accredited course focuses on Calcium, an important plant nutrient in fertilizer...
Integration of a new mode of action compound like Coragen into IPM and IRM programs to control...
New chemistry Rynaxypyr has proven effective against a wide range of economically important...
Connect With Us